Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Reshma Kewalramani currently holds 138,278 shares of VERTEX PHARMACEUTICALS INC / MA (VRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Reshma Kewalramani has been a net seller of VRTX stock. They have purchased $5.9M and sold $53.1M worth of shares.
Reshma Kewalramani's most recent insider trade was on Feb 24, 2026, when they sold 4,981 shares at $485.11 per share.
Reshma Kewalramani serves as Executive at VERTEX PHARMACEUTICALS INC / MA (VRTX). They have executed 115 insider transactions totaling $58.9M over their tenure at the company.
Reshma Kewalramani holds the position of Executive at VERTEX PHARMACEUTICALS INC / MA, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Reshma Kewalramani has shown a selling trading pattern, with $5.9M in total purchases and $53.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Reshma Kewalramani was on Jul 30, 2024, when they sold $7.7M worth of VRTX shares. This transaction involved 15,202 shares at $505.00 per share.
Reshma Kewalramani currently owns 138,278 shares of VERTEX PHARMACEUTICALS INC / MA (VRTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Reshma Kewalramani's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Reshma Kewalramani has 115 Form 4 filings on record as an insider at VERTEX PHARMACEUTICALS INC / MA.
Set alerts for Reshma Kewalramani and 40,000+ other insiders.